CCNB3
Basic information
Region (hg38): X:50202713-50351914
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCNB3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 51 | 62 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 51 | 15 | 5 |
Variants in CCNB3
This is a list of pathogenic ClinVar variants found in the CCNB3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-50288799-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
X-50288807-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
X-50288823-A-G | not specified | Uncertain significance (Nov 03, 2023) | ||
X-50294913-T-C | Likely benign (Sep 01, 2022) | |||
X-50294948-C-T | not specified | Uncertain significance (Sep 16, 2021) | ||
X-50308530-G-C | not specified | Uncertain significance (Jun 18, 2024) | ||
X-50308545-G-A | not specified | Likely benign (Nov 19, 2022) | ||
X-50308660-C-T | not specified | Uncertain significance (Apr 29, 2024) | ||
X-50308666-T-C | not specified | Likely benign (Apr 07, 2022) | ||
X-50308731-T-A | Benign (Jul 23, 2018) | |||
X-50308752-C-T | not specified | Likely benign (Aug 28, 2023) | ||
X-50308839-A-G | not specified | Uncertain significance (Apr 19, 2023) | ||
X-50308857-T-C | not specified | Uncertain significance (May 14, 2024) | ||
X-50308876-G-A | not specified | Uncertain significance (Jul 19, 2023) | ||
X-50308913-G-A | Likely benign (Apr 01, 2022) | |||
X-50308926-G-C | not specified | Uncertain significance (Nov 15, 2023) | ||
X-50308934-T-C | Benign (Jun 04, 2018) | |||
X-50308959-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
X-50308969-G-A | not specified | Likely benign (Mar 02, 2023) | ||
X-50309002-T-C | not specified | Likely benign (Feb 12, 2024) | ||
X-50309062-A-G | not specified | Conflicting classifications of pathogenicity (Sep 01, 2021) | ||
X-50309140-A-G | not specified | Uncertain significance (Jun 22, 2021) | ||
X-50309253-C-T | not specified | Uncertain significance (Sep 14, 2021) | ||
X-50309392-C-G | not specified | Uncertain significance (Jul 14, 2023) | ||
X-50309399-G-T | not specified | Uncertain significance (Jun 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCNB3 | protein_coding | protein_coding | ENST00000376042 | 11 | 127546 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.859 | 0.141 | 125388 | 2 | 2 | 125392 | 0.0000160 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.840 | 429 | 481 | 0.892 | 0.0000333 | 9223 |
Missense in Polyphen | 39 | 81.757 | 0.47702 | 1757 | ||
Synonymous | 1.33 | 169 | 192 | 0.878 | 0.0000138 | 2608 |
Loss of Function | 4.34 | 6 | 32.8 | 0.183 | 0.00000230 | 736 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000795 | 0.0000545 |
Finnish | 0.0000732 | 0.0000464 |
European (Non-Finnish) | 0.0000251 | 0.0000176 |
Middle Eastern | 0.0000795 | 0.0000545 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cyclins are positive regulatory subunits of the cyclin- dependent kinases (CDKs), and thereby play an essential role in the control of the cell cycle, notably via their destruction during cell division. Its tissue specificity suggest that it may be required during early meiotic prophase I. {ECO:0000269|PubMed:12185076}.;
- Pathway
- Cell cycle - Homo sapiens (human);FoxO signaling pathway - Homo sapiens (human);Cellular senescence - Homo sapiens (human);Progesterone-mediated oocyte maturation - Homo sapiens (human);Cell Cycle;miRNA Regulation of DNA Damage Response;DNA Damage Response
(Consensus)
Intolerance Scores
- loftool
- 0.418
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.6
Haploinsufficiency Scores
- pHI
- 0.149
- hipred
- N
- hipred_score
- 0.465
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccnb3
- Phenotype
Gene ontology
- Biological process
- regulation of cyclin-dependent protein serine/threonine kinase activity;mitotic cell cycle;protein phosphorylation;regulation of mitotic nuclear division;positive regulation of cell population proliferation;regulation of G2/M transition of mitotic cell cycle;positive regulation of cell cycle;cell division;meiotic cell cycle
- Cellular component
- cyclin-dependent protein kinase holoenzyme complex;nucleus;cytoplasm;centrosome;nuclear speck
- Molecular function
- protein kinase activity;protein binding;cyclin-dependent protein serine/threonine kinase regulator activity;protein kinase binding